Bahram Valamehr
2018
In 2018, Bahram Valamehr earned a total compensation of $2.6M as Chief Development Officer at Fate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $117,250 |
|---|---|
| Option Awards | $2,138,235 |
| Salary | $321,865 |
| Total | $2,577,350 |
Valamehr received $2.1M in option awards, accounting for 83% of the total pay in 2018.
Valamehr also received $117.3K in non-equity incentive plan and $321.9K in salary.
Rankings
In 2018, Bahram Valamehr's compensation ranked 4,541st out of 14,244 executives tracked by ExecPay. In other words, Valamehr earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,541 out of 14,244 | 68th |
Division Manufacturing | 1,702 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 613 out of 2,122 | 71st |
Industry group Drugs | 513 out of 1,811 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 101 out of 339 | 70th |
Source: SEC filing on March 22, 2019.
Valamehr's colleagues
We found three more compensation records of executives who worked with Bahram Valamehr at Fate Therapeutics in 2018.